Vir Biotechnology Statistics
Total Valuation
VIR has a market cap or net worth of $1.04 billion. The enterprise value is -$390.23 million.
| Market Cap | 1.04B |
| Enterprise Value | -390.23M |
Important Dates
The next confirmed earnings date is Thursday, May 2, 2024, after market close.
| Earnings Date | May 2, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
VIR has 135.84 million shares outstanding. The number of shares has decreased by -0.50% in one year.
| Shares Outstanding | 135.84M |
| Shares Change (YoY) | -0.50% |
| Shares Change (QoQ) | +0.24% |
| Owned by Insiders (%) | 14.14% |
| Owned by Institutions (%) | 75.83% |
| Float | 88.97M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 4.36 |
| PS Ratio | 12.00 |
| Forward PS | 23.70 |
| PB Ratio | 0.65 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.06, with a Debt / Equity ratio of 0.07.
| Current Ratio | 9.06 |
| Quick Ratio | n/a |
| Debt / Equity | 0.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -34.90% and return on invested capital (ROIC) is -40.21%.
| Return on Equity (ROE) | -34.90% |
| Return on Assets (ROA) | -27.70% |
| Return on Capital (ROIC) | -40.21% |
| Revenue Per Employee | $146,814 |
| Profits Per Employee | -$1.05M |
| Employee Count | 587 |
| Asset Turnover | 0.04 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -13.08M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -68.35% in the last 52 weeks. The beta is 0.41, so VIR's price volatility has been lower than the market average.
| Beta (1Y) | 0.41 |
| 52-Week Price Change | -68.35% |
| 50-Day Moving Average | 10.00 |
| 200-Day Moving Average | 10.69 |
| Relative Strength Index (RSI) | 27.49 |
| Average Volume (30 Days) | 1,050,638 |
Short Selling Information
The latest short interest is 4.96 million, so 3.65% of the outstanding shares have been sold short.
| Short Interest | 4.96M |
| Short Previous Month | 5.43M |
| Short % of Shares Out | 3.65% |
| Short % of Float | 5.57% |
| Short Ratio (days to cover) | 5.16 |
Income Statement
In the last 12 months, VIR had revenue of $86.18 million and -$615.06 million in losses. Loss per share was -$4.59.
| Revenue | 86.18M |
| Gross Profit | 83.42M |
| Operating Income | -684.31M |
| Pretax Income | -628.14M |
| Net Income | -615.06M |
| EBITDA | -601.03M |
| EBIT | -628.14M |
| Loss Per Share | -$4.59 |
Balance Sheet
The company has $1.54 billion in cash and $111.67 million in debt, giving a net cash position of $1.42 billion or $10.48 per share.
| Cash & Cash Equivalents | 1.54B |
| Total Debt | 111.67M |
| Net Cash | 1.42B |
| Net Cash Per Share | $10.48 |
| Equity / Book Value | 1.59B |
| Book Value Per Share | 11.71 |
| Working Capital | 1.41B |
Cash Flow
In the last 12 months, operating cash flow was -$778.79 million and capital expenditures -$21.57 million, giving a free cash flow of -$800.36 million.
| Operating Cash Flow | -778.79M |
| Capital Expenditures | -21.57M |
| Free Cash Flow | -800.36M |
| FCF Per Share | -$5.97 |
Margins
Gross margin is 96.79%, with operating and profit margins of -794.04% and -713.69%.
| Gross Margin | 96.79% |
| Operating Margin | -794.04% |
| Pretax Margin | -728.87% |
| Profit Margin | -713.69% |
| EBITDA Margin | -697.41% |
| EBIT Margin | -728.87% |
| FCF Margin | -928.71% |
Dividends & Yields
VIR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.50% |
| Shareholder Yield | 0.50% |
| Earnings Yield | -59.50% |
| FCF Yield | -77.42% |
Analyst Forecast
The average price target for VIR is $33.29, which is 335.73% higher than the current price. The consensus rating is "Buy".
| Price Target | $33.29 |
| Price Target Difference | 335.73% |
| Analyst Consensus | Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | 53.68% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
VIR has an Altman Z-Score of 1.56 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.56 |
| Piotroski F-Score | 3 |